-
J. Thromb. Haemost. · Nov 2016
Comparative StudyA comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin.
- K W Belk, M Laposata, and C Craver.
- MedAssets, Inc., Health Data Analytics, Charlotte, NC, USA.
- J. Thromb. Haemost. 2016 Nov 1; 14 (11): 2148-2157.
AbstractEssentials Anti-activated factor X (Anti-Xa) monitoring is more precise than activated partial thromboplastin (aPTT). 20 804 hospitalized cardiovascular patients monitored with Anti-Xa or aPTT were analyzed. Adjusted transfusion rates were significantly lower for patients monitored with Anti-Xa. Adoption of Anti-Xa protocols could reduce transfusions among cardiovascular patients in the US.© 2016 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis.
Notes
Knowledge, pearl, summary or comment to share?